Refilling and switching of antiepileptic drugs and seizure-related events.

Clinical Pharmacology and Therapeutics
Joshua J GagneS Schneeweiss

Abstract

We sought to estimate the risk of seizure-related events associated with refilling prescriptions for antiepileptic drugs (AEDs) and to estimate the effect of switching between brand-name and generic drugs or between two generic versions of the same drug. We conducted a case-crossover study using health-care databases from British Columbia, Canada, among AED users who had an emergency room visit or hospitalization for seizure (index seizure-related event), defined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes 345.xx (epilepsy and recurrent seizures) and 780.3x (convulsions), between 1997 and 2005. AED prescription refilling itself was associated with 2.3-fold elevated odds of seizure-related events when the refill occurred within 21 days before the index event (odds ratio (OR) 2.31; 95% confidence interval (CI) 1.56-3.44). The OR was 2.75 (95% CI 0.88-8.64) for refills that involved switching, yielding a refill-adjusted OR for switching of 1.19 (95% CI 0.35-3.99). Refilling the same AED prescription was associated with an elevated risk of seizure-related events whether or not the refill involved switching from a brand-name to a generic product.

References

Jan 1, 1991·Annals of the New York Academy of Sciences·J G Harter, C C Peck
May 1, 1995·Epidemiology·S Suissa
Jul 1, 1995·American Journal of Epidemiology·M A MittlemanJ M Robins
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·F M Besag
Jul 10, 2001·Pharmaceutical Research·M C MeyerL J Lesko
Oct 18, 2002·Journal of Clinical Epidemiology·Sebastian SchneeweissRobert J Glynn
Mar 1, 2003·Epilepsy & Behavior : E&B·Joyce A. CramerVincent Rienzi
May 3, 2005·Journal of Clinical Epidemiology·Sebastian Schneeweiss, Jerry Avorn
Mar 1, 2006·Seizure : the Journal of the British Epilepsy Association·P CrawfordG Kramer
Apr 18, 2007·Neurology·K LiowUNKNOWN American Academy of Neurology
Jun 8, 2007·Clinical Pharmacology and Therapeutics·S Schneeweiss
Sep 12, 2007·Archives of Internal Medicine·William H ShrankPaul Shekelle
Jul 1, 2008·Epilepsy & Behavior : E&B·Michel J BergKenneth J Tomaszewski
Oct 11, 2008·Epilepsy & Behavior : E&B·Tania Beltran PapsdorfKore Liow
Jan 8, 2009·Epilepsy & Behavior : E&B·Ranjani ManjunathAlan B Ettinger
Jun 30, 2009·Pharmacotherapy·Karen L RascatiTeresa A Mann
Jul 21, 2009·Epilepsy & Behavior : E&B·Ryan N HansenSean D Sullivan
Dec 18, 2009·Current Medical Research and Opinion·Scott T DevineAndrew Behm

❮ Previous
Next ❯

Citations

Oct 27, 2011·The Annals of Pharmacotherapy·Mikiko Yamada, Timothy E Welty
May 3, 2012·The Annals of Pharmacotherapy·Shilpa A KinikarWilliam H Bentley
Nov 23, 2017·Clinical Pharmacology and Therapeutics·Ameet SarpatwariAaron S Kesselheim
Sep 14, 2013·Pharmacoepidemiology and Drug Safety·Giulia P ConsiglioSuzanne M Cadarette
Apr 11, 2020·International Journal of Clinical Pharmacy·Johanna WeitzelOlaf Rose
Jun 25, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Aaron S Kesselheim, Joshua J Gagne
Jan 25, 2012·Pharmacoepidemiology and Drug Safety·Joshua J GagneSebastian Schneeweiss
Sep 5, 2013·Journal of the American Geriatrics Society·Joshua J GagneWilliam H Shrank
Aug 19, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joshua J GagneSarah K Dutcher
Mar 25, 2011·International Journal of Clinical Pharmacy·Steven Simoens
Nov 26, 2010·Expert Review of Neurotherapeutics·Josemir W SanderJürgen Bauer
Apr 27, 2013·CNS Drugs·Maren Carbon, Christoph U Correll
May 24, 2013·Current Hypertension Reports·Rhonda M Cooper-DeHoff, William J Elliott
Nov 14, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ameet SarpatwariAaron S Kesselheim
Oct 12, 2010·Clinical Pharmacology and Therapeutics·L S Boylan
Feb 14, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Pieter DylstSteven Simoens
Jan 12, 2019·Journal of General Internal Medicine·Ameet SarpatwariAaron S Kesselheim
Oct 1, 2018·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Lars Erik KristensenArnold G Vulto
Jan 30, 2013·American Journal of Law & Medicine·Michelle Hottinger, Bryan A Liang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.